Saudi Central Bank raised its holdings in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 89.9% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 37,735 shares of the medical research company

MW Advisory LLC purchased a new stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 2,910 shares of the medical research company

TD Waterhouse Canada Inc. decreased its position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 15.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 103,282 shares of the medical resea

Explore AMGEN Inc. (AMGN) single-stock futures prices. Compare Standard and Micro contracts, contract months, price changes, tick values, and specifications.

Amgen stock is trading near its 52-week high in early September 2026, after strong Q2 2026 earnings

NWF Advisory Services Inc. cut its holdings in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 41.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,766 shares of the medical research company

Amgen Inc. (NASDAQ:AMGN) reported that Repatha reduced the risk of all-cause mortality by 20% in a prespecified secondary analysis of the Phase 3 VESALIUS-CV trial. The study enrolled more than 12,000 high-risk adults without a previous heart attack or stroke and followed them for a median of 4.6 years. The mortality reduction began to appear […]

Tudor Financial Inc. lessened its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 36.8% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 9,784 shares of the medical research company

Concurrent Investment Advisors LLC raised its stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 19.9% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 51,650 shares of the medical research company

NEOS Investment Management LLC boosted its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 10.8% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 409,827 shares of the medical research company

Amgen stock is trading close to its 52-week high in early September 2026 as investors respond to rai

Amgen stock is trading just below its 52-week high after double-digit revenue growth and higher 2026

Amgen stock is trading close to its recent 52-week high as of early September 2026, supported by a s

Amgen stock is trading close to its 52-week high after a Q2 2026 earnings beat and new Repatha cardi